Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
Journal of Pharmaceutical Sciences
|
April 1, 1990
Effects of truncal vagotomy and partial gastrectomy on the pharmacokinetics of propranolol enantiomers in dogs
H G Schaefer, D Harrison, M P Hocking, et al.
European Journal of Clinical Pharmacology
|
January 1, 1997
Pharmacokinetic-pharmacodynamic modelling as a tool to evaluate the clinical relevance of a drug-food interaction for a nisoldipine controlled-release dosage form
H G Schaefer, R Heinig, G Ahr, et al.
European Journal of Clinical Pharmacology
|
January 1, 1992
Pharmacokinetics of the active metabolite of the prodrug repirinast in healthy Caucasian volunteers after a single oral dose
D Beermann, H G Schaefer, M Wargenau, et al.
Journal of the American Chemical Society
|
January 31, 2012
On the redox properties of cyclotetraphosphines. A novel dication rearrangement
H G Schaefer, W W Schoeller, J Niemann, et al.
Journal of Pharmaceutical Sciences
|
January 1, 1993
Effect of food on the pharmacokinetics of the active metabolite of the prodrug repirinast
H G Schaefer, D Beermann, R Horstmann, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
January 1, 1990
Simultaneous assay of propranolol, diltiazem and metabolites of diltiazem in human plasma by liquid chromatography
F F Ververs, H G Schaefer, J F Lefevre, et al.
Anaesthesia
|
April 1, 1994
Teaching fibreoptic intubation in anaesthetised patients
H G Schaefer, S C Marsch, H L Keller, et al.
British Journal of Anaesthesia
|
June 1, 1994
Prolonged decrease in heart rate variability after elective hip arthroplasty
S C Marsch, K Skarvan, H G Schaefer, et al.
British Journal of Pharmacology
|
November 6, 2007
Contribution of the active metabolite M1 to the pharmacological activity of tesofensine in vivo: a pharmacokinetic-pharmacodynamic modelling approach
T Lehr, A Staab, C Tillmann, et al.
Clinical Pharmacology and Therapeutics
|
January 1, 1999
Population pharmacokinetic-pharmacodynamic modeling of moxonidine using 24-hour ambulatory blood pressure measurements
G Hempel, M O Karlsson, D P de Alwis, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
Journal of Pharmaceutical Sciences
|
April 1, 1990
Effects of truncal vagotomy and partial gastrectomy on the pharmacokinetics of propranolol enantiomers in dogs
H G Schaefer, D Harrison, M P Hocking, et al.
European Journal of Clinical Pharmacology
|
January 1, 1997
Pharmacokinetic-pharmacodynamic modelling as a tool to evaluate the clinical relevance of a drug-food interaction for a nisoldipine controlled-release dosage form
H G Schaefer, R Heinig, G Ahr, et al.
European Journal of Clinical Pharmacology
|
January 1, 1992
Pharmacokinetics of the active metabolite of the prodrug repirinast in healthy Caucasian volunteers after a single oral dose
D Beermann, H G Schaefer, M Wargenau, et al.
Journal of the American Chemical Society
|
January 31, 2012
On the redox properties of cyclotetraphosphines. A novel dication rearrangement
H G Schaefer, W W Schoeller, J Niemann, et al.
Journal of Pharmaceutical Sciences
|
January 1, 1993
Effect of food on the pharmacokinetics of the active metabolite of the prodrug repirinast
H G Schaefer, D Beermann, R Horstmann, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
January 1, 1990
Simultaneous assay of propranolol, diltiazem and metabolites of diltiazem in human plasma by liquid chromatography
F F Ververs, H G Schaefer, J F Lefevre, et al.
Anaesthesia
|
April 1, 1994
Teaching fibreoptic intubation in anaesthetised patients
H G Schaefer, S C Marsch, H L Keller, et al.
British Journal of Anaesthesia
|
June 1, 1994
Prolonged decrease in heart rate variability after elective hip arthroplasty
S C Marsch, K Skarvan, H G Schaefer, et al.
British Journal of Pharmacology
|
November 6, 2007
Contribution of the active metabolite M1 to the pharmacological activity of tesofensine in vivo: a pharmacokinetic-pharmacodynamic modelling approach
T Lehr, A Staab, C Tillmann, et al.
Clinical Pharmacology and Therapeutics
|
January 1, 1999
Population pharmacokinetic-pharmacodynamic modeling of moxonidine using 24-hour ambulatory blood pressure measurements
G Hempel, M O Karlsson, D P de Alwis, et al.
Page
of 5